GPI-1485
≥99%
- Product Code: 190814
CAS:
186268-78-0
| Molecular Weight: | 241.28 g./mol | Molecular Formula: | C₁₂H₁₉NO₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
GPI-1485 is primarily investigated for its neuroprotective properties, particularly in the context of neurodegenerative diseases. It functions as an immune modulator with the ability to enhance the clearance of misfolded proteins and reduce neuroinflammation. This makes it a candidate for therapeutic development in conditions such as Parkinson’s disease and Alzheimer’s disease.
One of its key applications is in promoting neuronal survival by supporting the function of neurotrophic factors, which are essential for the growth and maintenance of neurons. Studies have shown that GPI-1485 can reduce the loss of dopaminergic neurons in preclinical models, suggesting potential in slowing disease progression in Parkinson’s.
It has also been explored for its ability to modulate T-cell responses in the central nervous system, helping to create a more favorable environment for neuronal repair. Due to its small molecular size and ability to cross the blood-brain barrier, it is considered suitable for oral administration in clinical settings.
While still under investigation, its application focuses on early intervention strategies to preserve neurological function before extensive neuronal damage occurs.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 G | 10-20 days | ฿16,570.00 |
+
-
|
| 0.010 G | 10-20 days | ฿24,860.00 |
+
-
|
| 0.025 G | 10-20 days | ฿45,570.00 |
+
-
|
GPI-1485
GPI-1485 is primarily investigated for its neuroprotective properties, particularly in the context of neurodegenerative diseases. It functions as an immune modulator with the ability to enhance the clearance of misfolded proteins and reduce neuroinflammation. This makes it a candidate for therapeutic development in conditions such as Parkinson’s disease and Alzheimer’s disease.
One of its key applications is in promoting neuronal survival by supporting the function of neurotrophic factors, which are essential for the growth and maintenance of neurons. Studies have shown that GPI-1485 can reduce the loss of dopaminergic neurons in preclinical models, suggesting potential in slowing disease progression in Parkinson’s.
It has also been explored for its ability to modulate T-cell responses in the central nervous system, helping to create a more favorable environment for neuronal repair. Due to its small molecular size and ability to cross the blood-brain barrier, it is considered suitable for oral administration in clinical settings.
While still under investigation, its application focuses on early intervention strategies to preserve neurological function before extensive neuronal damage occurs.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :